ONTOLOGY REPORT - ANNOTATIONS
Term: astemizole
Accession: CHEBI:2896
browse the term
Definition: A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
Synonyms: exact_synonym: 1-(4-fluorobenzyl)-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-amine
related_synonym: 1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole; 1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole; Astemison; C28H31FN4O; COc1ccc(CCN2CCC(CC2)Nc2nc3ccccc3n2Cc2ccc(F)cc2)cc1; InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31); InChIKey=GXDALQBWZGODGZ-UHFFFAOYSA-N; astemizol; astemizolum
xref_casrn: 68844-77-9
xref: Beilstein:4830190 "Beilstein Registry Number"; ChEMBL:165605 "ChEMBL COMPOUND"; ChemIDplus:68844-77-9 "CAS Registry Number"; DrugBank:68844-77-9 "CAS Registry Number"; DrugBank:DB00637 "DrugBank"; KEGG COMPOUND:68844-77-9 "CAS Registry Number"; KEGG COMPOUND:C06832 "KEGG COMPOUND"; KEGG DRUG:68844-77-9 "CAS Registry Number"; KEGG DRUG:D00234 "KEGG DRUG"
xref_mesh: MESH:D016589
xref: Patent:EP5318 "Patent"; Patent:US4219559 "Patent"
astemizole
G
Ak3
adenylate kinase 3
increases expression
EXP
1
232,658,879
232,684,083
RGD:6480464
CTD
G
Alas2
aminolevulinate, delta-, synthase 2
increases expression
EXP
RGD:6480464
CTD
G
Angpt2
angiopoietin 2
increases expression
EXP
16
75,891,757
75,942,255
RGD:6480464
CTD
G
Atp1b1
ATPase, Na+/K+ transporting, beta 1 polypeptide
increases expression
EXP
13
80,214,056
80,234,576
RGD:6480464
CTD
G
Atp1b2
ATPase, Na+/K+ transporting, beta 2 polypeptide
decreases expression
EXP
10
56,418,323
56,424,465
RGD:6480464
CTD
G
Atp5e
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
increases expression
EXP
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
decreases expression
EXP
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bmp1
bone morphogenetic protein 1
decreases expression
EXP
15
50,878,144
50,922,313
RGD:6480464
CTD
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
decreases expression
EXP
2
223,840,650
224,108,082
RGD:6480464
CTD
G
Cat
catalase
increases expression
EXP
3
88,654,077
88,686,212
RGD:6480464
CTD
G
Ccl7
chemokine (C-C motif) ligand 7
decreases expression
EXP
10
70,267,281
70,269,131
RGD:6480464
CTD
G
Cebpb
CCAAT/enhancer binding protein (C/EBP), beta
increases expression
EXP
3
158,826,021
158,827,848
RGD:6480464
CTD
G
Cebpg
CCAAT/enhancer binding protein (C/EBP), gamma
decreases expression
EXP
1
87,552,695
87,559,447
RGD:6480464
CTD
G
Cfh
complement factor H
decreases expression
EXP
13
53,252,249
53,355,987
RGD:6480464
CTD
G
Colec12
collectin sub-family member 12
decreases expression
EXP
18
996,297
1,188,288
RGD:6480464
CTD
G
Cox6c-ps1
cytochrome c oxidase subunit VIc, pseudogene
increases expression
EXP
19
54,397,944
54,398,802
RGD:6480464
CTD
G
Crh
corticotropin releasing hormone
multiple interactions
EXP
2
104,764,023
104,765,887
RGD:6480464
CTD
G
Cxcl3
chemokine (C-X-C motif) ligand 3
decreases expression
EXP
14
18,767,306
18,787,340
RGD:6480464
CTD
G
Cxcl9
chemokine (C-X-C motif) ligand 9
decreases expression
EXP
14
17,284,085
17,288,996
RGD:6480464
CTD
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
multiple interactions
ISO
5
116,702,370
116,729,722
RGD:6480464
CTD
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
decreases methylation
ISO
5
116,702,370
116,729,722
RGD:6480464
CTD
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
increases metabolic processing
ISO
5
116,702,370
116,729,722
RGD:6480464
CTD
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
decreases methylation
ISO
5
116,702,370
116,729,722
RGD:6480464
CTD
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases degradation
ISO
12
9,517,016
9,541,000
RGD:6480464
CTD
G
Eaf1
ELL associated factor 1
increases expression
EXP
16
6,938,938
6,953,687
RGD:6480464
CTD
G
Egln1
EGL nine homolog 1 (C. elegans)
increases expression
EXP
19
55,080,670
55,118,226
RGD:6480464
CTD
G
Eif4a1
eukaryotic translation initiation factor 4A1
increases expression
EXP
10
56,484,232
56,489,739
RGD:6480464
CTD
G
Errfi1
ERBB receptor feedback inhibitor 1
decreases expression
EXP
5
168,012,683
168,025,963
RGD:6480464
CTD
G
Etv5
ets variant 5
decreases expression
EXP
11
80,846,286
80,904,013
RGD:6480464
CTD
G
Fcer1a
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
multiple interactions
EXP
13
89,429,982
89,436,507
RGD:6480464
CTD
G
Gdf10
growth differentiation factor 10
increases expression
EXP
16
9,558,781
9,570,656
RGD:6480464
CTD
G
Gimap1
GTPase, IMAP family member 1
increases expression
EXP
4
76,829,536
76,833,423
RGD:6480464
CTD
G
Gpm6b
glycoprotein m6b
increases expression
EXP
X
48,746,584
48,788,414
RGD:6480464
CTD
G
Gpx4
glutathione peroxidase 4
increases expression
EXP
7
11,162,521
11,165,318
RGD:6480464
CTD
G
Hexb
hexosaminidase B
increases secretion
EXP
2
27,649,188
27,672,231
RGD:6480464
CTD
G
Hexb
hexosaminidase B
multiple interactions
EXP
2
27,649,188
27,672,231
RGD:6480464
CTD
G
Hrh1
histamine receptor H 1
multiple interactions
ISO
4
150,431,239
150,432,699
RGD:6480464
CTD
G
Hrh1
histamine receptor H 1
multiple interactions
ISO
4
150,431,239
150,432,699
RGD:6480464
CTD
G
Hspa8
heat shock 70kDa protein 8
increases expression
EXP
8
43,784,035
43,787,760
RGD:6480464
CTD
G
Hspb8
heat shock protein B8
increases expression
EXP
12
41,407,166
41,421,565
RGD:6480464
CTD
G
Hsph1
heat shock 105/110 protein 1
decreases expression
EXP
12
5,794,645
5,811,453
RGD:6480464
CTD
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
8
20,040,177
20,051,939
RGD:6480464
CTD
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
decreases expression
EXP
1
238,571,300
238,576,443
RGD:6480464
CTD
G
Igf1
insulin-like growth factor 1
multiple interactions
ISO
7
24,531,669
24,605,742
RGD:6480464
CTD
G
Igsf6
immunoglobulin superfamily, member 6
decreases expression
EXP
1
179,911,684
179,922,158
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
multiple interactions
ISO
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il36rn
interleukin 36 receptor antagonist
increases expression
EXP
3
2,530,402
2,536,999
RGD:6480464
CTD
G
Il7r
interleukin 7 receptor
decreases expression
EXP
2
59,103,992
59,128,004
RGD:6480464
CTD
G
Itga8
integrin, alpha 8
increases expression
EXP
17
86,427,191
86,649,268
RGD:6480464
CTD
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
decreases activity
ISO
13
108,129,617
108,407,815
RGD:6480464
CTD
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
multiple interactions
ISO
13
108,129,617
108,407,815
RGD:6480464
CTD
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
affects binding
ISO
13
108,129,617
108,407,815
RGD:6480464
CTD
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
decreases activity
ISO
13
108,129,617
108,407,815
RGD:6480464
CTD
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
multiple interactions
ISO
13
108,129,617
108,407,815
RGD:6480464
CTD
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
decreases activity
ISO
13
108,129,617
108,407,815
RGD:6480464
CTD
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
decreases activity
ISO
13
108,129,617
108,407,815
RGD:6480464
CTD
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
decreases activity
ISO
13
108,129,617
108,407,815
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
decreases activity
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
affects binding
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
decreases activity
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
affects localization
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
affects binding
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
affects binding
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
decreases activity
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
decreases activity
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
decreases activity
EXP
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
affects localization
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
decreases activity
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
decreases activity
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
decreases activity
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
decreases activity
ISO
4
6,192,644
6,224,285
RGD:6480464
CTD
G
Kcnq2
potassium voltage-gated channel, KQT-like subfamily, member 2
multiple interactions
ISO
3
170,227,938
170,282,887
RGD:6480464
CTD
G
Kcnq3
potassium voltage-gated channel, KQT-like subfamily, member 3
multiple interactions
ISO
7
103,325,185
103,627,045
RGD:6480464
CTD
G
LOC100362888
rCG52099-like
increases expression
EXP
15
41,841,298
41,844,727
RGD:6480464
CTD
G
Maoa
monoamine oxidase A
decreases expression
EXP
X
17,678,960
17,745,908
RGD:6480464
CTD
G
Mapt
microtubule-associated protein tau
affects binding
ISO
10
93,411,098
93,508,762
RGD:6480464
CTD
G
Mmp2
matrix metallopeptidase 2
decreases expression
EXP
19
15,246,036
15,275,061
RGD:6480464
CTD
G
Ms4a6a
membrane-spanning 4-domains, subfamily A, member 6A
decreases expression
EXP
1
214,046,885
214,057,578
RGD:6480464
CTD
G
Mtus1
microtubule associated tumor suppressor 1
decreases expression
EXP
16
54,611,502
54,664,075
RGD:6480464
CTD
G
Myh6
myosin, heavy chain 6, cardiac muscle, alpha
increases expression
EXP
15
33,044,506
33,068,098
RGD:6480464
CTD
G
Ndufs7
NADH dehydrogenase (ubiquinone) Fe-S protein 7
increases expression
EXP
7
10,963,916
10,971,188
RGD:6480464
CTD
G
Ndufv2
NADH dehydrogenase (ubiquinone) flavoprotein 2
increases expression
EXP
9
104,852,714
104,873,325
RGD:6480464
CTD
G
Necab1
N-terminal EF-hand calcium binding protein 1
decreases expression
EXP
5
29,427,273
29,664,037
RGD:6480464
CTD
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
increases expression
EXP
5
64,713,468
64,753,311
RGD:6480464
CTD
G
Oasl
2'-5'-oligoadenylate synthetase-like
decreases expression
EXP
12
42,956,466
42,969,826
RGD:6480464
CTD
G
Osbpl3
oxysterol binding protein-like 3
increases expression
EXP
4
78,521,743
78,600,559
RGD:6480464
CTD
G
Osgepl1
O-sialoglycoprotein endopeptidase-like 1
increases expression
EXP
9
45,164,778
45,178,715
RGD:6480464
CTD
G
Park7
parkinson protein 7
increases expression
EXP
5
168,050,149
168,061,616
RGD:6480464
CTD
G
Pcdh17
protocadherin 17
decreases expression
EXP
15
66,391,901
66,482,530
RGD:6480464
CTD
G
Peli2
pellino E3 ubiquitin protein ligase family member 2
increases expression
EXP
15
24,227,734
24,371,242
RGD:6480464
CTD
G
Prl8a3
prolactin family 8, subfamily a, member 3
decreases expression
EXP
RGD:6480464
CTD
G
Psmb5
proteasome (prosome, macropain) subunit, beta type 5
increases expression
EXP
15
32,689,859
32,694,364
RGD:6480464
CTD
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases expression
EXP
3
15,343,832
15,365,412
RGD:6480464
CTD
G
Pycrl
pyrroline-5-carboxylate reductase-like
increases expression
EXP
7
113,895,788
113,926,200
RGD:6480464
CTD
G
Pygm
phosphorylase, glycogen, muscle
increases expression
EXP
1
209,166,701
209,181,588
RGD:6480464
CTD
G
RGD1561089
RGD1561089
increases expression
EXP
RGD:6480464
CTD
G
S100a8
S100 calcium binding protein A8
increases expression
EXP
2
182,961,994
182,962,513
RGD:6480464
CTD
G
S100b
S100 calcium binding protein B
decreases expression
EXP
20
12,791,440
12,824,508
RGD:6480464
CTD
G
Sik1
salt-inducible kinase 1
decreases expression
EXP
20
10,282,203
10,291,735
RGD:6480464
CTD
G
Slc1a1
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
increases expression
EXP
1
232,469,746
232,549,584
RGD:6480464
CTD
G
Sod2
superoxide dismutase 2, mitochondrial
increases expression
EXP
1
41,862,997
41,870,327
RGD:6480464
CTD
G
Sqstm1
sequestosome 1
increases expression
EXP
10
35,751,300
35,762,630
RGD:6480464
CTD
G
Tf
transferrin
decreases expression
EXP
8
108,217,774
108,244,487
RGD:6480464
CTD
G
Tgfb2
transforming growth factor, beta 2
increases expression
EXP
13
102,718,703
102,818,768
RGD:6480464
CTD
G
Tlr2
toll-like receptor 2
decreases expression
EXP
2
175,607,990
175,613,992
RGD:6480464
CTD
G
Tlr7
toll-like receptor 7
decreases expression
EXP
X
47,330,737
47,356,841
RGD:6480464
CTD
G
Tmod1
tropomodulin 1
increases expression
EXP
5
62,578,142
62,668,760
RGD:6480464
CTD
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
2
212,277,654
212,297,376
RGD:6480464
CTD
G
Vcan
versican
decreases expression
EXP
2
19,712,629
19,801,443
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest